GlassScriptPhysician profile
Arnold A Brizuela
NPI 1528325818
$38,363.46
in general payments reported to CMS, 2019-2025
88 companies · $9,224 in 2025
The $9,224 reported for 2025 was more than what 89% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,415 · 2020: $1,922 · 2021: $4,439 · 2022: $6,145 · 2023: $6,934 · 2024: $8,283 · 2025: $9,224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $24K · Education: $262 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15.72 · Travel and Lodging: $6.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $24,157.49 |
| Education | $261.90 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15.72 |
| Travel and Lodging | $6.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $4,907.44 | 2019-2025 | Zilbrysq, Rystiggo, Briviact |
| Biogen, INC. | $2,712.91 | 2019-2025 | Vumerity, Tysabri, Spinraza |
| Alexion Pharmaceuticals, INC. | $2,149.44 | 2019-2025 | Ultomiris, Soliris |
| Novartis Pharmaceuticals Corporation | $2,098.56 | 2019-2025 | |
| Abbvie INC. | $2,089.16 | 2021-2025 | Botox, Ubrelvy, Qulipta |
| Lilly USA, LLC | $1,800.71 | 2019-2025 | Kisunla, Emgality, Reyvow |
| Neurocrine Biosciences, INC. | $1,564.15 | 2019-2025 | Ingrezza, Ongentys |
| Lundbeck LLC | $1,517.97 | 2020-2025 | Vyepti, Rexulti |
| Pfizer INC. | $1,443.63 | 2021-2025 | |
| Acadia Pharmaceuticals INC | $1,194.89 | 2020-2025 | Nuplazid, Daybue |
| Teva Pharmaceuticals USA, INC. | $1,089.14 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Eisai INC. | $1,038.85 | 2021-2025 | |
| Amneal Pharmaceuticals LLC | $933.21 | 2021-2025 | Crexont, Rytary |
| Amgen INC. | $865.25 | 2020-2025 | Uplizna, Aimovig |
| Supernus Pharmaceuticals, INC. | $744.31 | 2019-2025 | Qelbree |
Show all 88 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mdd US Operations, LLC | $714.51 | 2021-2025 | Gocovri, Gocovri |
| Emd Serono, INC. | $679.24 | 2020-2025 | Mavenclad |
| Allergan, INC. | $556.38 | 2019-2022 | |
| Genzyme Corporation | $528.95 | 2020-2025 | |
| Argenx US, INC. | $517.18 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Jazz Pharmaceuticals INC. | $510.11 | 2022-2024 | |
| Sk Life Science, INC. | $506.82 | 2020-2025 | Xcopri |
| Otsuka America Pharmaceutical, INC. | $496.23 | 2023-2025 | Nuedexta, Rexulti |
| Biohaven Pharmaceutical Holding Company LTD. | $438.50 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $356.03 | 2020-2021 | |
| Alnylam Pharmaceuticals INC. | $298.26 | 2022-2024 | Onpattro, Amvuttra |
| Zyla Life Sciences, INC. | $272.83 | 2019-2020 | |
| Grifols USA, LLC | $255.50 | 2022-2025 | Gamunex-C |
| Horizon Therapeutics Plc | $253.30 | 2021-2023 | Uplizna |
| Celgene Corporation | $245.68 | 2021-2023 | Zeposia |
| Ipsen Biopharmaceuticals, INC | $238.12 | 2023-2025 | Dysport |
| Octapharma USA, INC. | $224.37 | 2021-2025 | Panzyga |
| Janssen Biotech, INC. | $215.37 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $209.85 | 2020-2024 | Gammagard, Hyqvia |
| Aquestive Therapeutics, INC. | $208.65 | 2021-2022 | |
| Almatica Pharma LLC | $206.98 | 2021 | |
| Corium, LLC | $200.48 | 2022-2023 | Adlarity |
| Abbott Laboratories | $196.78 | 2021-2025 | Infinity |
| Tg Therapeutics, INC. | $195.48 | 2024-2025 | |
| Neurelis, INC. | $194.15 | 2022-2025 | Valtoco |
| Greenwich Biosciences, INC. | $169.54 | 2020-2021 | |
| Mallinckrodt Hospital Products INC. | $154.37 | 2021-2025 | Acthar |
| Ani Pharmaceuticals, INC. | $144.60 | 2024-2025 | Purified Cortrophin Gel |
| Axsome Therapeutics, INC. | $144.17 | 2025 | Symbravo, Sunosi |
| Merz Pharmaceuticals, LLC | $143.99 | 2023-2025 | Inbrija, Xeomin |
| Kyowa Kirin, INC. | $141.89 | 2021-2023 | Nourianz |
| Arbor Pharmaceuticals, INC. | $136.43 | 2019-2022 | |
| Acorda Therapeutics, INC | $135.57 | 2021-2023 | Inbrija |
| Avanir Pharmaceuticals, INC. | $134.83 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $132.34 | 2021-2022 | |
| Csl Behring | $124.37 | 2020-2022 | |
| Genentech USA, INC. | $116.78 | 2022-2025 | Ocrevus Zunovo, Ocrevus |
| Zogenix INC. | $112.34 | 2021 | |
| Boston Scientific Corporation | $109.60 | 2019-2023 | |
| Adamas Pharmaceuticals, INC. | $106.90 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $95.27 | 2022-2023 | Ponvory, Xarelto |
| Catalyst Pharmaceuticals, INC. | $94.43 | 2022-2025 | Fycompa, Firdapse |
| Harmony Biosciences LLC | $84.84 | 2022-2025 | |
| Cycle Pharmaceuticals INC | $81.04 | 2025 | Bafiertam, Tascenso Odt |
| Assertio Therapeutics, INC. | $79.03 | 2019-2020 | |
| Avadel Cns Pharmaceuticals, LLC | $79.00 | 2024-2025 | Lumryz |
| Azurity Pharmaceuticals, INC. | $77.55 | 2022-2023 | Horizant, Eprontia |
| Neuropace, INC. | $64.40 | 2024-2025 | |
| Upsher-Smith Laboratories LLC | $62.75 | 2021-2022 | |
| Ironshore Pharmaceuticals INC. | $61.50 | 2023 | Jornay Pm |
| Tanabe Pharma America, INC. | $58.72 | 2022-2024 | |
| Impel Pharmaceuticals INC. | $56.09 | 2023 | Trudhesa |
| Immedica Pharma US, INC. | $50.83 | 2022-2023 | |
| Ge Healthcare | $50.27 | 2025 | |
| Sumitomo Pharma America, INC. | $46.96 | 2023-2024 | Aptiom |
| Banner Life Sciences, LLC | $40.55 | 2022-2024 | |
| Vanda Pharmaceuticals INC. | $39.66 | 2020-2025 | Ponvory |
| Astrazeneca Pharmaceuticals LP | $32.99 | 2024-2025 | Wainua |
| C2n Diagnostics, LLC | $32.62 | 2025 | Precivityad2 |
| Collegium Pharmaceutical, INC. | $30.51 | 2022-2025 | Jornay Pm |
| Avion Pharmaceuticals | $30.42 | 2022 | |
| Scilex Pharmaceuticals INC. | $27.07 | 2024 | |
| Livanova USA, INC. | $27.00 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Medtronic, INC. | $25.57 | 2023 | Vanta Adaptivestim |
| Vertex Pharmaceuticals Incorporated | $23.02 | 2025 | |
| Electromed, INC. | $20.97 | 2023 | Smartvest |
| Vertical Pharmaceuticals, LLC | $19.99 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $19.46 | 2024 | Caplyta |
| Forte Bio-Pharma LLC | $17.16 | 2025 | Tanlor |
| Biomarin Pharmaceutical INC. | $14.80 | 2024 | Brineura |
| Cranial Technologies, INC | $14.79 | 2025 | Doc Band |
| Tonix Medicines, INC. | $14.31 | 2025 | Zembrace Symtouch |
| Travere Therapeutics, INC. | $12.80 | 2019-2022 |
Drugs and devices associated with these payments
Kesimpta $1,427Vumerity $1,280Ingrezza $1,239Ultomiris $1,231Nurtec Odt $1,159Zilbrysq $1,108Tysabri $1,037Rystiggo $1,016Botox $985Vyepti $935Leqembi $880Qulipta $690Ubrelvy $685Zavzpret $678Nuplazid $596Briviact $555Fintepla $539Rexulti $511Gocovri $475Austedo Xr $429Panzyga $362Kisunla $360Crexont $352Uplizna $343Rytary $327Emgality $291Nuedexta $262Paxlovid $258Vyvgart Hytrulo $253Vyvgart $244Reyvow $241Dysport $238Gamunex-C $228Nayzilam $226Amyvid $214Briumvi $195Epidiolex $176Onpattro $172Daybue $164Valtoco $157Purified Cortrophin Gel $145Adlarity $140Mavenclad $129Symbravo $127Acthar $121Amvuttra $102Qelbree $100Bafiertam $100Qalsody $98.86Spinraza $98.86Inbrija $98.48Ocrevus Zunovo $97.27Ongentys $85.82Tascenso Odt $81.04Soliris $79.73Xywav $79.57Lumryz $79.00Jornay Pm $74.96Zeposia $70.41Xeomin $66.65Octagam Immune Globulin (Human) $65.94Rns Neurostimulator Kit $64.40Comirnaty $58.43Trudhesa $56.09Firdapse $51.93Aubagio $51.80Avonex $49.06Horizant $47.48Fabrazyme $47.41Aptiom $46.96Infinity $46.23Gammagard $42.42Ponvory $40.54Aimovig $37.57Ocrevus $35.00Nourianz $34.85Wainua $32.99Precivityad2 $32.62Vyalev $28.27Ztlido $27.07Vns Therapy Sentiva Model 1000 Generator $27.00Vanta Adaptivestim $25.57Xarelto $23.35Mayzent $23.16Journavx $23.02Zepbound $22.50Xcopri $21.94Smartvest $20.97Fycompa $20.89Skyclarys $20.46Radicava $19.81Radicava Ors $19.81Caplyta $19.46Sunosi $17.39Ztalmy $17.22Tanlor $17.16Hyqvia $16.90Austedo $16.51Wakix $15.64Agamree $15.22
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arnold Brizuela listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.